Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
Clinical trial NCT02383212 · COMPLETED
Trial details
- NCT number
- NCT02383212
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-02
- Primary completion
- 2019-11-18
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.